-
公开(公告)号:AU2006201943A1
公开(公告)日:2006-06-01
申请号:AU2006201943
申请日:2006-05-10
Applicant: BAXTER INT
Inventor: SRIRAM RAJARAM , KIPP JAMES E , BRYNJELSEN SEAN , DOTY MARK J , WERLING JANE , REBBECK CHRISTINE L , WONG JOSEPH CHUNG TAK
-
公开(公告)号:MXPA05009936A
公开(公告)日:2006-05-31
申请号:MXPA05009936
申请日:2004-02-25
Applicant: BAXTER INT
Inventor: BRYNJELSEN SEAN
IPC: A61K31/496 , A61K9/10 , A61K9/14 , A61K9/16 , A61K31/12 , A61K31/337 , A61K31/495 , A61K31/55 , A61K31/573
Abstract: La presente invencion se refiere a la formacion de particulas pequenas o compuestos organicos mediante precipitacion de los compuestos organicos en un medio acuoso a fin de formar una pre-suspension seguida por adicion de energia para estabilizar una cubierta de la particula o para alterar la estructura de reticula de la particula. El proceso incluye las etapas de: (i) disolver el compuesto organico en el primer solvente miscible en agua a fin de formar una solucion; (ii) mezclar la solucion con el segundo solvente para definir una pre-suspension de particulas; y (iii) agregar energia a la pre-suspension para formar una suspension de particulas que tienen un tamano de particula eficaz promedio de menos de aproximadamente 100 mum. El proceso se utiliza preferentemente para preparar una suspension de particulas pequenas de un compuesto farmaceuticamente activo, escasamente soluble en agua, para suministro in vivo mediante una ruta de administracion tal como parenteral, oral, pulmonar, nasal, bucal, topica, oftalmica, recta, vaginal, transdermica o lo similar.
-
公开(公告)号:BR0116377A
公开(公告)日:2005-12-13
申请号:BR0116377
申请日:2001-12-20
Applicant: BAXTER INT
Inventor: KIPP JAMES E , WONG JOSEPH CHUNG TAK , DOTY MARK J , REBBECK CHRISTINE L , BRYNJELSEN SEAN , WERLING JANE , SRIRAM AJARAM
-
公开(公告)号:CA2517589A1
公开(公告)日:2004-09-30
申请号:CA2517589
申请日:2004-02-25
Applicant: BAXTER INT
Inventor: WONG JOSEPH CHUNG TAK , KIPP JAMES E , WERLING JANE , REBBECK CHRISTINE L , BRYNJELSEN SEAN , DOTY MARK J
IPC: A61K9/10 , A61K9/14 , A61K9/16 , A61K31/12 , A61K31/337 , A61K31/495 , A61K31/496 , A61K31/55 , A61K31/573
Abstract: The present invention is concerned with the formation of small particles or organic compounds by precipitating the organic compounds in an aqueous mediu m to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter the lattice structure of the particle. The process includes the steps of: (i) dissolving the organic compound in the water- miscible first solvent to form a solution; (ii) mixing the solution with the second solvent to define a presuspension of particles; and (iii) adding ener gy to the presuspension to form a suspension of particles having an average effective particle size of less than about 100 .mu.m. The process is preferably used to prepare a suspension of small particles of a poorly water - soluble, pharmaceutically active compound suitable for in vivo delivery by a n administrate route such as parenteral, oral, pulmonary, nasal, buccal, topic al ophthalmic, rectal, vaginal, transdermal or the like.
-
公开(公告)号:AU2004222362A1
公开(公告)日:2004-09-30
申请号:AU2004222362
申请日:2004-02-25
Applicant: BAXTER INT
Inventor: KIPP JAMES E , WONG JOSEPH CHUNG TAK , WERLING JANE , REBBECK CHRISTINE L , BRYNJELSEN SEAN
IPC: A61K9/10 , A61K9/14 , A61K9/16 , A61K31/12 , A61K31/337 , A61K31/495 , A61K31/496 , A61K31/55 , A61K31/573
Abstract: The present invention is concerned with the formation of small particles of organic compounds by precipitating the organic compounds in an aqueous medium to form a pre-suspension followed by adding energy to stabilize a coating of the particle or to alter the lattice structure of the particle. The process includes the steps of: (i) dissolving the organic compound in the water-miscible first solvent to form a solution; (ii) mixing the solution with the second solvent to define a presuspension of particles; and (iii) adding energy to the presuspension to form a suspension of particles having an average effective particle size of less than about 100 mum. The process is preferably used to prepare a suspension of small particles of a poorly water-soluble, pharmaceutically active compound suitable for in vivo delivery by an administrate route such as parenteral, oral, pulmonary, nasal, buccal, topical ophthalmic, rectal, vaginal, transdermal or the like.
-
26.
公开(公告)号:CA2461349A1
公开(公告)日:2003-04-03
申请号:CA2461349
申请日:2002-09-25
Applicant: BAXTER INT
Inventor: KIPP JAMES E , DUNHAM ANDREW J , DOTY MARK J , NARAYANAN KRISHNASWAMY , STERNBERG SHMUEL , JAYSWAL NAILESH , BRYNJELSEN SEAN
IPC: A61K9/14 , A61K9/19 , A61K9/51 , A61K31/496 , A61K45/00 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/18 , A61K47/20 , A61K47/24 , A61K47/28 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/42 , B01J13/04
Abstract: The present invention relates to a process for preparing submicron sized nanoparticles of a poorly water soluble compound by sonicating to evaporate a portion of the organic phase or by lyophilizing a dispersion or microdispersion of a multiphase system having an organic phase and an aqueou s phase, the organic phase havingthe poorly water soluble organic compound therein. The method is preferably used to prepare nanoparticles of a poorly water soluble, pharmaceutically active compound suitable for in vivo deliver y, particularly by parenteral routes.
-
公开(公告)号:CA2431705C
公开(公告)日:2010-10-05
申请号:CA2431705
申请日:2001-12-20
Applicant: BAXTER INT
Inventor: KIPP JAMES E , WONG JOSEPH CHUNG TAK , DOTY MARK J , REBBECK CHRISTINE L , BRYNJELSEN SEAN , WERLING JANE , SRIRAM RAJARAM
IPC: A61K9/20 , C07D407/14 , A61K9/10 , A61K9/14 , A61K9/16 , A61K9/51 , A61K31/495 , A61K31/496 , A61K47/12 , A61K47/14 , A61K47/18 , A61K47/20 , A61K47/24 , A61K47/28 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/42 , A61P31/10
Abstract: The present invention provides a method for preparing a suspension of a pharmaceutically-active compound, the solubility of which is greater in a water-miscible first organic solvent than in a second solvent which is aqueous. The process includes the steps of : (i) dissolving a first quantity of the pharmaceutically-active compound in the water-miscible first organic solvent to form a first solution ; (ii) mixing the first solution with the second solvent to precipitate the pharmaceutically-active compound ; and (iii) seeding the first solution or the second solvent or the presuspension.
-
公开(公告)号:DK1435909T3
公开(公告)日:2010-03-15
申请号:DK02773797
申请日:2002-10-18
Applicant: BAXTER INT
Inventor: KONKEL JAMIE TERESA , KIPP JAMES E , DOTY MARK J , REBBECK CHRISTINE L , BRYNJELSEN SEAN
IPC: A61K9/10 , A61K8/02 , A61K8/04 , A61K8/06 , A61K8/34 , A61K8/35 , A61K8/36 , A61K8/365 , A61K8/37 , A61K8/39 , A61K8/40 , A61K8/41 , A61K8/44 , A61K8/46 , A61K8/60 , A61K8/64 , A61K8/73 , A61K8/86 , A61K8/89 , A61K8/891 , A61K9/107 , A61K9/14 , A61K31/12 , A61K31/4985 , A61K31/58 , A61K47/02 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/16 , A61K47/18 , A61K47/20 , A61K47/26 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/42 , A61K47/44 , A61K47/46 , A61Q19/00
-
公开(公告)号:AU2002337894B2
公开(公告)日:2007-07-12
申请号:AU2002337894
申请日:2002-10-18
Applicant: BAXTER INT
Inventor: KONKEL JAMIE TERESA , DOTY MARK J , BRYNJELSEN SEAN , REBBECK CHRISTINE L , KIPP JAMES E
IPC: A61K9/10 , A61K8/02 , A61K8/04 , A61K8/06 , A61K8/34 , A61K8/35 , A61K8/36 , A61K8/365 , A61K8/37 , A61K8/39 , A61K8/40 , A61K8/41 , A61K8/44 , A61K8/46 , A61K8/60 , A61K8/64 , A61K8/73 , A61K8/86 , A61K8/89 , A61K8/891 , A61K9/107 , A61K9/14 , A61K31/12 , A61K31/4985 , A61K31/58 , A61K47/02 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/16 , A61K47/18 , A61K47/20 , A61K47/26 , A61K47/32 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/42 , A61K47/44 , A61K47/46 , A61Q19/00
Abstract: The present invention discloses a composition of a stable suspension of a poorly water soluble pharmaceutical agent or cosmetic in the form of particles of the pharmaceutical agent or cosmetic suspended in a frozen aqueous matrix and method for its preparation. The composition is stable for a prolonged period of time, preferably six months or longer and is suitable for parenteral, oral, or non-oral routes such as pulmonary (inhalation), ophthalmic, or topical administration.
-
公开(公告)号:AU2002249836B2
公开(公告)日:2006-12-14
申请号:AU2002249836
申请日:2001-12-20
Applicant: BAXTER INT
Inventor: BRYNJELSEN SEAN , REBBECK CHRISTINE L , KIPP JAMES E , WONG JOSEPH CHUNG TAK , DOTY MARK J , WERLING JANE , SRIRAM RAJARAM
-
-
-
-
-
-
-
-
-